Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03615599 · ClinicalTrials.gov registry record

Plant-based Diets and Risk of Cancer in the Adventist Health Study-2

A clinical trial of Cancer, Breast and Cancer Colorectal, sponsored by Loma Linda University.

Active
Registry status
96,000
Enrollment target
1
Study location

NCT03615599: Active study of Cancer, Breast and Cancer Colorectal, sponsored by Loma Linda University.

NCT03615599 is a study of Cancer, Breast and Cancer Colorectal that is active but no longer recruiting, run by Loma Linda University. The registered enrollment target is 96,000 participants, above the 468-participant average among 10 other Cancer, Breast trials with a reported enrollment target (20413% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03615599, a study of Cancer, Breast and Cancer Colorectal, is active but no longer recruiting, sponsored by Loma Linda University.

ACTIVE NOT RECRUITING
Registry status
96,000 participants
Enrollment target
1
Study location

Study Summary

The Adventist Health Study-2 is a long-term study, exploring the links between lifestyle, diet, and disease outcomes among Seventh-day Adventists. More than 96,000 church members from the U.S. and Canada are participating in the current study, AHS-2, conducted by researchers at the Loma Linda University School of Public Health.

Primary Outcome

Incident cases of breast cancer as found by linkage with state cancer registries will allow calculation of hazard ratios comparing extreme quintiles of dietary intakes. The focus is on meats, soy, and dairy intakes.

Study Locations (1)

California

  • Loma Linda University - Loma Linda

Trial Details

FieldValue
Enrollment Target 96,000 participants
Start Date 2002-02-01
Est. Completion 2028-12
Loma Linda University

237 total trials

What the registry record for NCT03615599 still lists

NCT03615599 is an observational study that tracks outcomes without assigning an intervention. Its 96,000 participants enrollment target places it among the larger protocols in the corpus, above the 468-participant average among 10 other Cancer, Breast trials with a reported enrollment target (20413% higher).

The record links to 3 conditions, with Cancer, Breast appearing as the primary indexed condition, and to 0 interventions.

NCT03615599 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03615599 about?

NCT03615599 is a clinical study titled "Plant-based Diets and Risk of Cancer in the Adventist Health Study-2". The Adventist Health Study-2 is a long-term study, exploring the links between lifestyle, diet, and disease outcomes among Seventh-day Adventists. More than 96,000 church members from the U.S. and Canada are participating in the current study, AHS-2, conducted by researchers at the Loma Linda Univer...

What is the current status of trial NCT03615599?

This trial is currently active not recruiting. The enrollment target is 96,000 participants. The study started on 2002-02-01. Estimated completion is 2028-12.

What conditions does trial NCT03615599 study?

This clinical trial studies the following conditions: Cancer, Breast, Cancer Colorectal, Cancer, Prostate.

Who is sponsoring clinical trial NCT03615599?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03615599 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer, Breast

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03615599's enrollment target sits among peer trials

96,000 1st of 10 higher than 10 of 10 other Cancer, Breast trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer, Breast trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01351545 · 99,999 participants

    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • NCT02620852 · 100,000 participants · NA

    Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

  • NCT03277365 · 100,000 participants · NA

    MyGeneRank: A Digital Platform for Next-Generation Genetic Studies

  • NCT04281823 · 100,000 participants

    DeBakey Cardiovascular Magnetic Resonance Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03615599, the US trial registry maintained by the National Library of Medicine. NCT03615599 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.